Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

✓ Peer-reviewed alzhub usefulness score 54 out of 100. Treatments

Topic: Risk, prevention and care in population studies

Plain-language summary

Guidelines recommend limiting antipsychotic treatment to short-term use ( Methods Using UK primary care data from the Clinical Practice Research Datalink, linked with hospital and mortality data from Jan 1, 1998, to March 31, 2021, we emulated two sets of target trials, one after 12 weeks of antipsychotic treatment and another after 24 weeks of antipsychotic treatment, to compare continuing treatment versus tapering treatment and continuing treatment versus abrupt discontinuation of treatment. Compared with continuation after 12 weeks of treatment, estimated risks of delirium and fracture under the tapering strategy corresponded to 24-month ARDs of -2·46% (95% CI -4·10 to -1·27) and -2·80% (-4·14 to -1·29), respectively. Similar results were found after 24 weeks of treatment and in sensitivity analyses.

What this study adds

Evidence grade: Moderate

This is a follow-up (cohort) study of 24,822 participants. This analysis of UK primary care data found that tapering antipsychotics after 12 weeks of treatment was linked to lower estimated risks of delirium and fracture compared with continuing treatment. Its stated limit: Observational target-trial emulation, not a randomised trial; relies on prescription records rather than confirmed drug taking; UK data from 1998-2021 may not transfer to other systems.

Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

APA 7th

Hopkinson, O. K., Chobanov, J., Goordeen, D., Man, K. K. C., Wong, I. C. K., Reeve, E., et al. (2026). Abrupt discontinuation and tapering of antipsychotics in older adults with dementia: a target trial emulation study. The lancet. Healthy longevity. https://doi.org/10.1016/j.lanhl.2026.100852

Vancouver

Hopkinson OK, Chobanov J, Goordeen D, Man KKC, Wong ICK, Reeve E, et al. Abrupt discontinuation and tapering of antipsychotics in older adults with dementia: a target trial emulation study. The lancet. Healthy longevity. 2026. doi:10.1016/j.lanhl.2026.100852. PMID: 42302797.

BibTeX

@article{hopkinson2026-42302797,
  author  = {Hopkinson, Olivia K and Chobanov, Jan and Goordeen, Darshna and Man, Kenneth K C and Wong, Ian C K and Reeve, Emily and Bell, J Simon and Wei, Li and others},
  title   = {{Abrupt discontinuation and tapering of antipsychotics in older adults with dementia: a target trial emulation study}},
  journal = {The lancet. Healthy longevity},
  year    = {2026},
  doi     = {10.1016/j.lanhl.2026.100852},
  pmid    = {42302797},
  url     = {https://doi.org/10.1016/j.lanhl.2026.100852}
}

Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.

Key findings

Why it matters

This analysis of UK primary care data found that tapering antipsychotics after 12 weeks of treatment was linked to lower estimated risks of delirium and fracture compared with continuing treatment. This supports guidance to limit antipsychotic use to short-term treatment in older adults with dementia.

Study details

Limitations

Observational target-trial emulation, not a randomised trial; relies on prescription records rather than confirmed drug taking; UK data from 1998-2021 may not transfer to other systems.

How this study scored 54/100
How this study's score is builtJournal tier 9 of 10; Journal's citation record 1 of 4; Study design 7 of 12; Strength of evidence 3 of 5; Peer-review validation 10 of 10; How recent 5 of 5; Sample size 4 of 4; Effect reported 3 of 3; Studied in people 3 of 3; Randomized / blinded 0 of 2; Times cited 0 of 7; Citations per year 0 of 5; Impact for its field and year 0 of 6; Cited by studies here 0 of 6; Still being cited 0 of 4; Senior author's track record 2 of 4; Institution's track record 2 of 3; Multicenter collaboration 2 of 3; Indexed in PubMed 2 of 2; Free to read left out, no data. 53 of the 98 points it could be judged on, which is 54 of 100. Total 54 of 100.53 of the 98 points we could judge = 54 of 100

Published in a leading specialty journal, and it is a cohort study following people over time. Scored zero for randomized / blinded because the record does not state it. We have no data on free to read, so that was left out: it earned 53 of the 98 points we could judge it on, which is 54 out of 100.

ComponentPointsWhy
Journal tier 9 / 10 Tier 2 — leading specialty journal (The lancet. Healthy longevity)
Journal's citation record 1 / 4 The Lancet Healthy Longevity: journal h-index 78 (OpenAlex, 2026-10-29)
Study design 7 / 12 A cohort study following people over time
Strength of evidence 3 / 5 Rated “moderate” in our summary
Peer-review validation 10 / 10 Peer-reviewed. Published as an article in a named peer-reviewed journal.
How recent 5 / 5 2026 — within 1 year(s) of the newest study here
Sample size 4 / 4 24,822 participants
Effect reported 3 / 3 Effect reported with a statistic (interval, p-value, ratio or similar)
Studied in people 3 / 3 Studied in people (participant count stated)
Randomized / blinded 0 / 2 No randomization or blinding stated — scores zero (not stated in the record — scored 0)
Times cited 0 / 7 Cited 0 times (OpenAlex, 2026-10-10)
Citations per year 0 / 5 0.0 citations a year over 2 year(s) since 2026
Impact for its field and year 0 / 6 Cited 0.0× the average for papers of its field and year (OpenAlex FWCI)
Cited by studies here 0 / 6 No other study in this library cites it
Still being cited 0 / 4 Cited 0 times in 2024–2026 (2026 still in progress; OpenAlex)
Senior author's track record 2 / 4 Last-listed author Wallis C. Y. Lau: h-index 30 (OpenAlex, whole career)
Institution's track record 2 / 3 University College London: institution h-index 2,029 (OpenAlex)
Multicenter collaboration 2 / 3 OpenAlex lists 9 institution(s) in 3 countries
Indexed in PubMed 2 / 2 Indexed in PubMed (PMID 42302797)
Free to read — / 2 Access not recorded — left out of this score
Points 53 / 98 Scored on 19 of 20 parts. We have no data for the rest, so they are left out: 53 of the 98 points we could judge it on is 54 out of 100.
Total 54 / 100 —

What each of these 20 components measures, and what this score is not →

Read the original

Full text: free to read — Unpaywall lists this copy as free to read: the link above (checked 10 Oct 2026).

Studies in the library that share something with this one. The line above each title says what.

Studies this one cites

Referenced by this study and also in the alzhub library, so you can read them here.

Related studies in Treatments from nearby years

Also tagged “trial”

783 studies in the library carry the topic tag “trial”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 783 tagged studies.

Studies sharing this one's topic tags

Similar studies

More on Treatments

See all studies in Treatments →